Brian C. Evanko - 27 Feb 2026 Form 4 Insider Report for Cigna Group (CI)

Role
Officer
Signature
Tyler Gratton, attorney-in-fact
Issuer symbol
CI
Transactions as of
27 Feb 2026
Net transactions value
-$1,370,751
Form type
4
Filing time
03 Mar 2026, 19:17:07 UTC
Previous filing
07 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Evanko Brian C Officer 900 COTTAGE GROVE ROAD, BLOOMFIELD Tyler Gratton, attorney-in-fact 02 Mar 2026 0001722909

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +6,428 +24% $0.000000 32,897 27 Feb 2026 Direct F1
transaction CI Common Stock, $.01 Par Value Award $0 +9,787 +30% $0.000000 42,684 27 Feb 2026 Direct F2
transaction CI Common Stock, $.01 Par Value Tax liability $856,611 -2,979 -7% $287.55 39,705 27 Feb 2026 Direct F3
transaction CI Common Stock, $.01 Par Value Tax liability $514,139 -1,788 -4.5% $287.55 37,917 27 Feb 2026 Direct F4
holding CI Common Stock, $.01 Par Value 25,614 27 Feb 2026 By GRAT F5
holding CI Common Stock, $.01 Par Value 909 27 Feb 2026 By 401(k) F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +15,082 $0.000000 15,082 27 Feb 2026 Common Stock, $.01 Par Value 15,082 $287.55 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2 These restricted shares vest in three equal annual installments beginning March 1, 2027.
F3 Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4 Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F5 Reflects the transfer by the Reporting Person of 25,614 shares of common stock on December 11, 2025 to the Reporting Person's grantor retained annuity trust.
F6 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F7 This option vests in three equal annual installments beginning March 1, 2027.